[Immunotherapy] Targeting nonviral antigens in viral-driven cancer
Adoptive cell transfer harnesses a patient's own T cells to destroy cancer. The strategy can successfully treat epithelial tumors driven by human papillomavirus (HPV), but it remains – [Read More]
Source: This Week in Science - Category: Science Authors: Priscilla N. Kelly Tags: Immunotherapy Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Genital Warts | Human Papillomavirus (HPV) | Immunotherapy | Science